The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program

被引:9
|
作者
Jafari, M
Masih, M
Emerson, JF
机构
[1] Univ Calif Irvine, Med Ctr, Dept Med, Orange, CA 92868 USA
[2] Univ Calif Irvine, Dept Pathol, Orange, CA 92868 USA
[3] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
来源
PHARMACOTHERAPY | 2001年 / 21卷 / 11期
关键词
D O I
10.1592/phco.21.17.1403.34416
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The leading cause of death in the United States is heart disease. Because an elevated serum cholesterol level is an independent risk factor for development of coronary heart disease (CHD), individuals older than 20 years of age are advised to have their cholesterol level checked every 5 years. Walk-in screening programs are becoming popular as a method of health care delivery. The program at the University of California-Irvine Medical Center administers point-of-care, low-cost lipid profile testing, directly involves patients in their own care, and provides individualized education to patients regarding cardiovascular risk reduction. A total of 301 patients participated in the program between August 1998 and September 2000. Fifty percent of them (150 patients) required intervention; 34% of these (52 patients) were previously undiagnosed. Their mean age was 57 +/- 13 years; 35% were women, 53% had two or more cardiac risk factors, and 5% had CHD. Based on the National Cholesterol Education Program guidelines, 29% had low-density lipoprotein levels above target, 23% had triglyceride levels higher than recommended, and 21% had high-density lipoprotein levels below target. It is our hope that our successful experience with the program will encourage pharmacists to develop similar programs.
引用
收藏
页码:1403 / 1406
页数:4
相关论文
共 50 条
  • [1] Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing
    Gerrald, Katherine R.
    Dixon, Dave L.
    Barnette, Debra J.
    Williams, Virginia G.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (02) : 120 - 125
  • [2] Establishing a community pharmacist-led vitamin D point-of-care testing service
    Busuttil, Catherine Anne
    Wirth, Francesca
    Azzopardi, Lilian M.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (12): : 1330 - 1335
  • [3] Role of pharmacist-provided point-of-care testing
    Kuhn, Catherine H.
    Klepser, Donald
    McCants, Hilary
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (06) : 572 - 573
  • [4] Pharmacist-led point-of-care testing in hypercholesterolaemia
    Cutajar, S.
    Azzopardi, L. M.
    Serracino-Inglott, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 212 - 213
  • [5] Pharmacist-Provided Pharmacogenetic Point-of-Care Testing Consultation Service: A Time and Motion Study
    Bright, David R.
    Klepser, Michael E.
    Murry, Logan
    Klepser, Donald G.
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (04) : 139 - 143
  • [6] Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program
    Papastergiou, John
    Trieu, Chantal Rene
    Saltmarche, Deborah
    Diamantouros, Artemis
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (04) : 450 - 456
  • [7] SCREENING FOR HYPERTENSION DURING CONSULTATION IN A WALK-IN SERVICE; LITERATURE REVIEW AND PROPOSED ALGORITHM
    Michaud, A.
    Lamarre-Cliche, M.
    Cloutier, L.
    JOURNAL OF HYPERTENSION, 2016, 34 : E286 - E286
  • [8] Management of a Point-of-Care Testing Program
    Gregory, Kim
    Lewandrowski, Kent
    CLINICS IN LABORATORY MEDICINE, 2009, 29 (03) : 433 - +
  • [9] Community pharmacist-led point-of-care colorectal cancer screening program: Early detection of colorectal cancer in high-risk patients
    Jairoun, Ammar Abdulrahman
    Al-Hemyari, Sabaa Saleh
    Shahwan, Moyad
    Zyoud, Samer H.
    Jaber, Ammar Ali Saleh
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2025, 21 (03): : 185 - 192
  • [10] Supplementary pharmacist prescribing and point-of-care testing in community pharmacy
    Micallef, T.
    Azzopardi, L. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 240 - 240